AN2 Therapeutics (NasdaqGS:ANTX) Update / briefing Transcript

AN2 Therapeutics (NasdaqGS:ANTX) Update / briefing March 04, 2026 09:30 AM ET Company ParticipantsAaron Gerds - Associate Professor of MedicineEric Easom - Co-Founder, Chairman, President, and CEOGeorge H. Talbot - Co-Founder and Senior Medical AdvisorConference Call ParticipantsStephen Willey - Managing Director and Senior Equity Research Analyst in HealthcareOperatorGood morning everyone, welcome to the AN2 Conference Call. This call is being recorded. At the end of the company's prepared remarks, we'll o ...